Perceptive Advisors
Latest statistics and disclosures from Perceptive Advisors's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CERE, FOLD, IOVA, ACLX, NUVL, and represent 27.01% of Perceptive Advisors's stock portfolio.
- Added to shares of these 10 stocks: IOVA (+$108M), Fusion Pharmaceuticals (+$87M), VKTX (+$82M), MDGL (+$75M), NBIX (+$74M), ITCI (+$66M), APGE (+$58M), PCVX (+$58M), CGON (+$57M), PRAX (+$50M).
- Started 26 new stock positions in ENGN, AGIO, PRAX, CMAX, RVNC, VKTX, NAMS, SYRS, AVBP, KYTX.
- Reduced shares in these 10 stocks: LIANY (-$257M), XBI (-$176M), Cymabay Therapeutics (-$95M), Rayzebio (-$46M), ACLX (-$43M), ABBV (-$24M), ASND (-$17M), MIRM (-$16M), EYPT (-$16M), TNGX (-$11M).
- Sold out of its positions in ACAD, ASND, BCAB, Caremax, Cymabay Therapeutics, CYTK, KRON, LPTX, LIANY, MIRM. Ambrx Biopharma, OLMA, Rayzebio, RGNX, TNGX, TERN, TVTX.
- Perceptive Advisors was a net buyer of stock by $713M.
- Perceptive Advisors has $5.8B in assets under management (AUM), dropping by 29.19%.
- Central Index Key (CIK): 0001224962
Tip: Access up to 7 years of quarterly data
Positions held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 108 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Cerevel Therapeutics Hldng I (CERE) | 7.9 | $456M | 11M | 42.27 |
|
|
Amicus Therapeutics (FOLD) | 5.7 | $331M | 28M | 11.78 |
|
|
Iovance Biotherapeutics (IOVA) | 5.0 | $286M | +60% | 19M | 14.82 |
|
Arcellx Common Stock (ACLX) | 4.8 | $274M | -13% | 3.9M | 69.55 |
|
Nuvalent Inc-a (NUVL) | 3.6 | $209M | -4% | 2.8M | 75.09 |
|
Apogee Therapeutics (APGE) | 3.1 | $179M | +47% | 2.7M | 66.45 |
|
Inhibrx | 2.6 | $149M | 4.3M | 34.96 |
|
|
Fusion Pharmaceuticals | 2.5 | $146M | +148% | 6.8M | 21.32 |
|
Rhythm Pharmaceuticals (RYTM) | 2.5 | $142M | +51% | 3.3M | 43.33 |
|
Vaxcyte (PCVX) | 2.3 | $132M | +77% | 1.9M | 68.31 |
|
Soleno Therapeutics (SLNO) | 2.3 | $132M | 3.1M | 42.80 |
|
|
Medtronic SHS (MDT) | 2.2 | $125M | +46% | 1.4M | 87.15 |
|
Madrigal Pharmaceuticals (MDGL) | 2.0 | $115M | +184% | 430k | 267.04 |
|
Springworks Therapeutics (SWTX) | 1.9 | $111M | +15% | 2.3M | 49.22 |
|
Neurocrine Biosciences (NBIX) | 1.9 | $111M | +197% | 804k | 137.92 |
|
Immunovant (IMVT) | 1.7 | $99M | +31% | 3.1M | 32.31 |
|
Spyre Therapeutics Com New (SYRE) | 1.7 | $97M | 2.6M | 37.93 |
|
|
Biohaven (BHVN) | 1.6 | $94M | 1.7M | 54.69 |
|
|
Solid Biosciences Com New (SLDB) | 1.6 | $92M | +97% | 6.9M | 13.32 |
|
Astria Therapeutics (ATXS) | 1.6 | $91M | +61% | 6.5M | 14.07 |
|
Axsome Therapeutics (AXSM) | 1.5 | $88M | +6% | 1.1M | 79.80 |
|
Viking Therapeutics (VKTX) | 1.4 | $82M | NEW | 994k | 82.00 |
|
Evolus (EOLS) | 1.4 | $81M | +45% | 5.8M | 14.00 |
|
Lyra Therapeutics (LYRA) | 1.4 | $79M | 13M | 6.22 |
|
|
Disc Medicine (IRON) | 1.3 | $77M | +21% | 1.2M | 62.26 |
|
Cargo Therapeutics (CRGX) | 1.3 | $77M | 3.4M | 22.32 |
|
|
Intra Cellular Therapies (ITCI) | 1.3 | $73M | +877% | 1.1M | 69.20 |
|
Natera (NTRA) | 1.2 | $69M | -10% | 757k | 91.46 |
|
Crinetics Pharmaceuticals In (CRNX) | 1.2 | $69M | +17% | 1.5M | 46.81 |
|
Meiragtx Holdings (MGTX) | 1.2 | $69M | 11M | 6.07 |
|
|
Sarepta Therapeutics (SRPT) | 1.2 | $68M | +16% | 526k | 129.46 |
|
Miragen Therapeutics (VRDN) | 1.1 | $64M | +111% | 3.7M | 17.51 |
|
Verona Pharma Sponsored Ads (VRNA) | 1.1 | $61M | -2% | 3.8M | 16.09 |
|
Applied Therapeutics (APLT) | 1.0 | $58M | +85% | 8.5M | 6.80 |
|
Cg Oncology (CGON) | 1.0 | $57M | NEW | 1.3M | 43.90 |
|
CryoLife (AORT) | 1.0 | $57M | +186% | 2.7M | 21.16 |
|
Arvinas Ord (ARVN) | 0.9 | $51M | +249% | 1.2M | 41.28 |
|
Celcuity (CELC) | 0.9 | $51M | +59% | 2.4M | 21.60 |
|
Praxis Precision Medicines I Com New (PRAX) | 0.9 | $50M | NEW | 822k | 61.02 |
|
Rocket Pharmaceuticals (RCKT) | 0.8 | $49M | +5% | 1.8M | 26.94 |
|
Immatics SHS (IMTX) | 0.8 | $48M | +31% | 4.6M | 10.51 |
|
Tarsus Pharmaceuticals (TARS) | 0.8 | $47M | 1.3M | 36.35 |
|
|
Bridgebio Pharma (BBIO) | 0.8 | $44M | -19% | 1.4M | 30.92 |
|
Adma Biologics (ADMA) | 0.7 | $43M | 6.4M | 6.60 |
|
|
Edgewise Therapeutics (EWTX) | 0.7 | $42M | +317% | 2.3M | 18.24 |
|
Verrica Pharmaceuticals (VRCA) | 0.7 | $42M | 7.1M | 5.92 |
|
|
Intuitive Surgical Com New (ISRG) | 0.7 | $41M | +85% | 102k | 399.09 |
|
Xenon Pharmaceuticals (XENE) | 0.7 | $38M | -18% | 892k | 43.05 |
|
Nautilus Biotechnology (NAUT) | 0.6 | $37M | 13M | 2.94 |
|
|
Akero Therapeutics (AKRO) | 0.6 | $35M | +43% | 1.4M | 25.26 |
|
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.6 | $35M | NEW | 3.1M | 11.30 |
|
Landos Biopharma Com New | 0.6 | $32M | 1.5M | 21.48 |
|
|
Ocular Therapeutix (OCUL) | 0.5 | $30M | NEW | 3.3M | 9.10 |
|
Treace Med Concepts (TMCI) | 0.5 | $30M | +84% | 2.3M | 13.05 |
|
Cabaletta Bio (CABA) | 0.5 | $29M | -14% | 1.7M | 17.06 |
|
Protagonist Therapeutics (PTGX) | 0.5 | $29M | +159% | 994k | 28.93 |
|
Irhythm Technologies (IRTC) | 0.5 | $28M | NEW | 245k | 116.00 |
|
Aldeyra Therapeutics (ALDX) | 0.5 | $28M | 8.6M | 3.27 |
|
|
Autolus Therapeutics Spon Ads (AUTL) | 0.5 | $28M | +136% | 4.3M | 6.38 |
|
Acrivon Therapeutics Common Stock (ACRV) | 0.4 | $22M | 3.0M | 7.15 |
|
|
Pepgen (PEPG) | 0.4 | $21M | NEW | 1.4M | 14.70 |
|
Revolution Medicines (RVMD) | 0.3 | $20M | -24% | 619k | 32.23 |
|
Abbvie (ABBV) | 0.3 | $19M | -55% | 107k | 182.10 |
|
Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.3 | $17M | +311% | 339k | 50.23 |
|
Engene Holdings (ENGN) | 0.3 | $17M | NEW | 999k | 16.95 |
|
Livanova SHS (LIVN) | 0.3 | $17M | NEW | 299k | 55.94 |
|
Athira Pharma (ATHA) | 0.3 | $15M | 5.4M | 2.74 |
|
|
Tactile Systems Technology, In (TCMD) | 0.3 | $15M | +27% | 903k | 16.25 |
|
Health Sciences Acq Corp 2 (OBIO) | 0.2 | $13M | +4% | 2.5M | 5.27 |
|
Axogen (AXGN) | 0.2 | $13M | +92% | 1.6M | 8.07 |
|
Eyepoint Pharmaceuticals Com New (EYPT) | 0.2 | $12M | -55% | 590k | 20.67 |
|
Zymeworks Del (ZYME) | 0.2 | $11M | 1.1M | 10.52 |
|
|
Rapt Therapeutics (RAPT) | 0.2 | $11M | -42% | 1.2M | 8.98 |
|
Tyra Biosciences (TYRA) | 0.2 | $11M | +85% | 669k | 16.40 |
|
Procept Biorobotics Corp (PRCT) | 0.2 | $10M | NEW | 211k | 49.42 |
|
Morphic Hldg (MORF) | 0.2 | $10M | +405% | 288k | 35.20 |
|
Silverback Therapeutics (SPRY) | 0.2 | $8.9M | NEW | 867k | 10.22 |
|
Arcutis Biotherapeutics (ARQT) | 0.1 | $7.4M | NEW | 750k | 9.91 |
|
Arrivent Biopharma (AVBP) | 0.1 | $7.4M | NEW | 415k | 17.86 |
|
Precision Biosciences Com New (DTIL) | 0.1 | $6.5M | NEW | 481k | 13.56 |
|
Cogent Biosciences (COGT) | 0.1 | $5.9M | -21% | 883k | 6.72 |
|
Kalvista Pharmaceuticals (KALV) | 0.1 | $5.9M | NEW | 500k | 11.86 |
|
Immunitybio (IBRX) | 0.1 | $5.7M | NEW | 1.1M | 5.37 |
|
Amylyx Pharmaceuticals Call Option (AMLX) | 0.1 | $5.6M | +5% | 2.0M | 2.84 |
|
Macrogenics (MGNX) | 0.1 | $5.6M | -38% | 378k | 14.72 |
|
Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.1 | $5.2M | NEW | 500k | 10.40 |
|
X4 Pharmaceuticals (XFOR) | 0.1 | $4.9M | 3.5M | 1.39 |
|
|
Spdr Ser Tr S&p Biotech Put Option (XBI) | 0.1 | $4.7M | -97% | 50k | 94.89 |
|
Establishment Labs Holdings Ord (ESTA) | 0.1 | $4.2M | 82k | 50.90 |
|
|
Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.1 | $4.1M | NEW | 175k | 23.65 |
|
Absci Corp (ABSI) | 0.1 | $4.0M | NEW | 700k | 5.68 |
|
Female Health (VERU) | 0.1 | $3.9M | 5.6M | 0.70 |
|
|
Kyverna Therapeutics (KYTX) | 0.1 | $3.7M | NEW | 150k | 24.84 |
|
Trinity Biotech Spons Adr New (TRIB) | 0.1 | $3.7M | NEW | 1.8M | 2.04 |
|
Nanobiotix Sponsored Ads (NBTX) | 0.1 | $3.6M | 555k | 6.50 |
|
|
Envveno Medical (NVNO) | 0.1 | $3.4M | 623k | 5.44 |
|
|
Novavax Com New Put Option (NVAX) | 0.1 | $3.3M | -50% | 700k | 4.78 |
|
Revance Therapeutics (RVNC) | 0.1 | $3.0M | NEW | 600k | 4.92 |
|
Agios Pharmaceuticals Call Option (AGIO) | 0.1 | $2.9M | NEW | 100k | 29.24 |
|
Forte Biosciences (FBRX) | 0.0 | $2.3M | 3.3M | 0.70 |
|
|
Singular Genomics Systems In (OMIC) | 0.0 | $1.1M | 2.1M | 0.51 |
|
|
Kura Oncology (KURA) | 0.0 | $1.0M | NEW | 48k | 21.33 |
|
Vbi Vaccines Inc Cda Com New (VBIV) | 0.0 | $757k | -8% | 1.3M | 0.60 |
|
Syros Pharmaceuticals Com New (SYRS) | 0.0 | $625k | NEW | 117k | 5.35 |
|
Caremax Cl A New (CMAX) | 0.0 | $591k | NEW | 123k | 4.82 |
|
Revolution Medicines *w Exp 12/17/202 (RVMDW) | 0.0 | $46k | 250k | 0.18 |
|
|
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $5.0k | 167k | 0.03 |
|
|
Caremax *w Exp 06/08/202 (CMAXW) | 0.0 | $1.0k | 60k | 0.02 |
|
Past Filings by Perceptive Advisors
SEC 13F filings are viewable for Perceptive Advisors going back to 2010
- Perceptive Advisors 2024 Q1 filed May 15, 2024
- Perceptive Advisors 2023 Q4 restated filed Feb. 26, 2024
- Perceptive Advisors 2023 Q4 filed Feb. 14, 2024
- Perceptive Advisors 2023 Q3 filed Nov. 14, 2023
- Perceptive Advisors 2023 Q2 restated filed Aug. 24, 2023
- Perceptive Advisors 2023 Q2 filed Aug. 14, 2023
- Perceptive Advisors 2023 Q1 restated filed May 16, 2023
- Perceptive Advisors 2023 Q1 filed May 15, 2023
- Perceptive Advisors 2022 Q4 filed Feb. 14, 2023
- Perceptive Advisors 2022 Q3 filed Nov. 14, 2022
- Perceptive Advisors 2022 Q2 filed Aug. 15, 2022
- Perceptive Advisors 2022 Q1 filed May 16, 2022
- Perceptive Advisors 2021 Q4 amended filed May 4, 2022
- Perceptive Advisors 2021 Q4 restated filed April 13, 2022
- Perceptive Advisors 2021 Q4 filed Feb. 14, 2022
- Perceptive Advisors 2021 Q3 restated filed Dec. 3, 2021